Amendment to the Capital Requirements Regulation in the area of resolution ("daisy chain" proposal)

EESC opinion: Amendment to the Capital Requirements Regulation in the area of resolution ("daisy chain" proposal)

Key points:

The EESC

  • deems it is necessary to incorporate directly into the Capital Requirements Regulation (CRR) a dedicated prudential treatment related to the indirect subscription of instruments eligible for internal Minimum Requirement for own funds and Eligible Liabilities (MREL) (to address the identified inconsistencies between the CRR and the Bank recovery and resolution directive (BRRD));
  • recommends clearer CRR provisions on the comparison between the sum of the actual Total Loss Absorbing Capacity (TLAC) requirements of all the resolution groups within a global systemically important institutions (G-SII) group with a multiple point of entry (MPE) resolution strategy with the theoretical single point of entry (SPE) requirement of that G-SII group;
  • stresses that it is necessary to amend the formula for the calculation of the TLAC/MREL surplus of a subsidiary in the context of the general deduction regime applicable to G-SIIs with an MPE resolution strategy, to avoid that the TLAC/MREL surplus of a given subsidiary is overestimated;
  • draws attention to the fact that some CRR provisions applicable to G-SIIs with an MPE resolution strategy should be clarified to allow for the consideration of subsidiaries established outside of the EU and/or where TLAC is applicable at a later stage. This would align the CRR with the corresponding TLAC principle agreed internationally, which is applicable with respect to subsidiaries established in all Financial Stability Board (FSB) jurisdictions;
  • recommends some targeted clarifications in the context of the requirement for own funds and eligible liabilities for institutions that are material subsidiaries of non-EU G-SIIs ('internal TLAC'), in order to ensure that debt instruments issued by those institutions meet all eligibility criteria for eligible liabilities instruments.